Jan Stenvang
- Cancer Research top 0.5%
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 20
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 8
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 12
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 9
- Immunology top 5%
- Genetics top 5%
- Co-authors
- Sakari KauppinenMorten LindowSusanna ObadAndreas PetriJesper WengelSimon FredrikssonMartin LundbergErika Assarsson
- Partner nations
- DenmarkChinaUnited States
In The Last Decade
Jan Stenvang
91 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 2.1k
- Molecular Biology 3.4k
- Oncology 802
- Immunology 597
- Genetics 225
Countries citing papers authored by Jan Stenvang
This map shows the geographic impact of Jan Stenvang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Stenvang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Stenvang more than expected).
Fields of papers citing papers by Jan Stenvang
This network shows the impact of papers produced by Jan Stenvang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Stenvang. The network helps show where Jan Stenvang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Stenvang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 14 | |
| 5 | 2019 | 5 | |
| 6 | 2016 | 27 | |
| 7 | 2016 | 6 | |
| 8 | 2016 | 30 | |
| 9 | 2016 | 33 | |
| 10 | 2015 | 21 | |
| 11 | 2014 | 16 | |
| 12 | 2014 | 9 | |
| 13 | 2013 | 16 | |
| 14 | 2012 | 435 | |
| 15 | 2011 | 498 | |
| 16 | 2009 | 163 | |
| 17 | 2007 | 86 | |
| 18 | LNA-antisense rivals siRNA for gene silencing. | 2004 | 61 |
| 19 | 2004 | 43 | |
| 20 | 2004 | 22 |
About Jan Stenvang
Jan Stenvang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 93 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (20 papers), MicroRNA in disease regulation (18 papers), Drug Transport and Resistance Mechanisms (12 papers), Colorectal Cancer Treatments and Studies (12 papers), RNA Interference and Gene Delivery (10 papers), Cancer-related molecular mechanisms research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.4k citations) and Oncology (802 citations). Jan Stenvang has collaborated with scholars based in Denmark, China and United States. Frequent co-authors include Sakari Kauppinen, Morten Lindow, Susanna Obad, Andreas Petri, Jesper Wengel, Simon Fredriksson, Martin Lundberg, Erika Assarsson, Johan Björkesten and Daniel Ekman. Their work appears in journals such as BMC Cancer, Cancer Research, Journal of Clinical Oncology, Scientific Reports and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.